Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body. Albumin is the major carrier molecule in the human body for […]
New York, NY March 9, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces a study on critically ill patients utilizing blood volume measurement and pulmonary artery catheterization (PAC). Pulmonary artery catheterization, an invasive procedure, involves threading a catheter into the heart to measure pressures. Millions of […]
NEW YORK, NY–(Marketwired – Feb 29, 2016) – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, expects to be filing a Form N-CSR within the next week disclosing its schedule of portfolio holdings as of December 31, 2015. Copies of the form will be mailed to the Company’s shareholders and will be […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.